A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer
暂无分享,去创建一个
Young Tae Kim | Y. Song | C. Cho | Jong-Hyeok Kim | Sang-Yoon Park | H. Kim | Chan-Yong Park | Y. B. Kim | Y. Song | Beob-Jong Kim | Byoungchan Kim | Chan‐Yong Park